Phase 3 Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men and women aged 50 or older who are not able to have children
- People who have been diagnosed with Alzheimer's disease and scored at or above certain thresholds on two standard memory and mood assessment tools at the screening visit (confirm with trial site)
- People whose Alzheimer's disease treatments and overall condition have been stable for at least one month
- Women who could still become pregnant may be eligible if they have had a tubal ligation or hysterectomy, or have gone through menopause (defined as no menstrual period for 12 months, with a blood test to confirm if there is any uncertainty)
- People who are able to give written consent to take part, either personally or through a legal representative
Who may not be able to join:
- People who have had a stroke at any point in the past
- People who have had a brain injury within the last 14 days
- People with depression that is not currently well controlled
- People with type 1 or type 2 diabetes that is not well controlled (based on a specific blood sugar measurement)
- People with severe difficulty swallowing
- People who are fed through a stomach tube (PEG feeding)
- People with ongoing, long-term diarrhoea
- People with chronic kidney disease above a certain level of severity (confirm with trial site)
- People with active asthma at the time of their screening visit
- People with a history of a rare inherited condition called phenylketonuria
- People with a known allergy to any substances used in the study
- People with a known active cancer
- People who have used dietary supplements such as vitamins, omega-3 products, or plant sterol/stanol products within one week before joining
- People who have used antibiotics or other antimicrobial medicines within one week before joining
- People with a history of drug or alcohol misuse
- People whom the trial investigator considers unsuitable for any reason, such as concerns about their ability to follow the study requirements
- People who have taken part in another clinical trial involving an unapproved drug within three months before this study begins
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sevki SAHIN, Prof. Dr., Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, University of Health Sciences Istanbul 34766, Turkiye
Phone: +90 216 606 33 00
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-Cog) score from baseline to end-of-treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.